ストックスクリーナーアプリを入手
1.65
4.43%
0.07
Imunon Inc (IMNN) 最新ニュース
Armistice Capital (IMNN) discloses 9.99% Imunon stake via Master Fund - Stock Titan
IMUNON to Hold First Quarter 2025 Financial Results and Business Update Conference Call on Monday, May 12, 2025 - kalkine.ca
Imunon Inc (NASDAQ: IMNN) Share Price, IMNN Stock News, IMNN Share Price & Updates - Kalkine
Earnings call transcript: Imunon beats Q2 2026 EPS forecast as shares stay weak - Investing.com UK
Imunon (IMNN) Q2 2026 Earnings Call Transcript - The Globe and Mail
Imunon Q2 2026 Loss Shrinks 42.6%: -$0.54/Share vs -$0.94 Expected - AlphaStreet
Imunon Q2 2026 Earnings Call Transcript - MarketBeat
Imunon Adopts New Equity-Based Executive Compensation Program - TipRanks
Imunon, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Imunon, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Form 8K Imunon Inc For: 11 August By Investing.com - Investing.com Nigeria
Q2 2026 Imunon Inc Earnings Call Transcript - GuruFocus
Imunon Inc (IMNN) Advances Phase 3 Trial Amidst Challenging Valu - GuruFocus
Imunon, Inc. 2Q 2026: Net loss $(2.83M), EPS $(0.54) — 10-Q Summary - TradingView
IMUNON Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Imunon Q2 net loss widens slightly as R&D costs rise - TradingView
IMUNON reports $2.8 million Q2 loss as OVATION 3 enrollment advances - Quiver Quantitative
Imunon reports Q2 2026 net loss $2.8M; cash $6.9M, advances Phase 3 OVATION 3 - TradingView
BRIEF-Imunon Q2 EPS USD -0.54 - TradingView
Imunon Inc expected to post a loss of 93 cents a shareEarnings Preview - TradingView
Imunon Inc. (CBO0.SG) balance sheet - Yahoo Finance UK
Imunon (IMNN.US) will release its earnings report on August 11. - Moomoo
Imunon (IMNN) General Counsel Susan Eylward Sells 2,541 Shares - GuruFocus
Imunon, Inc. (IMNN) director granted 6,934 shares in lieu of fees - Stock Titan
Imunon (IMNN) director granted 6,934 shares of stock for board fees - Stock Titan
Imunon (IMNN) grants director 6,934 shares instead of cash board fees - Stock Titan
Imunon (NASDAQ: IMNN) awards director 6,180 shares for board fees - Stock Titan
Imunon, Inc. (IMNN) general counsel grants and sells 2,541 shares - Stock Titan
Imunon, Inc. (IMNN) grants chair 6,358 shares instead of cash salary - Stock Titan
Imunon, Inc. (IMNN) CMO granted stock in lieu of cash pay - Stock Titan
Imunon, Inc. (IMNN) CEO awarded 5,010-share stock grant as compensation - Stock Titan
IMUNON to Hold Second Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, August 11, 2026 - The Manila Times
IMUNON Plans Phase 3 Ovarian Cancer Update on Aug. 11 - Stock Titan
Imunon (IMNN.US) will release its earnings report on August 4. - Moomoo
IMUNON reports faster-than-expected enrollment in ovarian cancer trial By Investing.com - Investing.com Nigeria
IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer - GlobeNewswire
Imunon Reports Strong Enrollment Momentum In Phase 3 Ovation 3 Trial Of Imnn-001 In Advanced Ovarian Cancer - TradingView
IMNN|Imunon Inc|Price:1.514|Chg%:+0.004 - TradingKey
Imunon Inc (IMNN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Imunon Inc (IMNN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Imunon Inc (IMNN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Imunon Inc (IMNN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Imunon Inc (IMNN) Cash Flow - TradingKey
IMNN|Imunon Inc|Price:1.510|Chg%:-0.150 - TradingKey
Imunon Inc. (IMNN) Q1 2026 Earnings: Narrower-Than-Expected Loss as Clinical Progress ContinuesEarnings Cycle Report - dars.gov.et
Imunon, Inc. Revenue Breakdown – NASDAQ:IMNN - TradingView
Imunon Inc (IMNN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Imunon, Inc. (IMNN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Imunon, Inc. (IMNN) stock price, news, quote and history - Yahoo Finance UK
Analysts Offer Insights on Healthcare Companies: Agios Pharma (AGIO) and Imunon (IMNN) - The Globe and Mail
Price to earnings forward of Imunon, Inc. – NASDAQ:IMNN - TradingView
IMUNON presents promising Phase 2 data for IMNN... - Pluang
IMUNON presents ovarian cancer therapy data at AACR conference - Investing.com
IMUNON to Present IMNN-001 Data at Inaugural AACR Conference on Drug Discovery and Development - The Manila Times
IMUNON presents ovarian cancer therapy data at AACR conference By Investing.com - Investing.com Canada
Maxim Group Maintains Imunon(IMNN.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Price to earnings forward of Imunon, Inc. – LSE:0HUZ - TradingView
Imunon’s IL-12 gene therapy shows early safety signal while reducing ovarian cancer residual disease - AllSci
IMUNON Reports Preliminary Phase II MRD Data As Phase III Ovarian Cancer Trial Advances - insights.citeline.com
IMUNON's IL-12 Therapy Breaks Ovarian Cancer Safety Barrier - AllSci
0.52%
0.07%
大文字化:
|
ボリューム (24 時間):